January 10, 2018

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Key Points

Key points are not available for this paper at this time.

Abstract

The wide range of immune-related adverse effects associated with immune checkpoint blockade can complicate this effective therapy and limit its use in patients with cancer. This review surveys the adverse effects and their management.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Postow et al. (Wed,) studied this question.

www.synapsesocial.com/papers/68f8c3ca24b0bc2d859006ba — DOI: https://doi.org/10.1056/nejmra1703481

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4· 1995 · 2,889 citations
Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis· 2015 · 426 citations
REITER'S DISEASE AND HL-A 27· 1973 · 367 citations
Vitiligo in a case of vaccinia virus-treated melanoma· 1964 · 82 citations
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors

Authors

Michael A. Postow

Robert Sidlow

Matthew D. Hellmann

Journals

New England Journal of Medicine

Actions

Institutions

Cornell University

Memorial Sloan Kettering Cancer Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion